Anticoagulant medication — "blood thinners" — is a category of drug that significantly affects how elective surgery is planned and managed. The peri-operative management of anticoagulants is one of the most consequential medication decisions in surgical care, and it needs to be handled with the supervision of the clinician who prescribed the anticoagulant, not improvised by the overseas surgeon or by the patient. This guide explains what to do before, during, and after an overseas procedure if you are on anticoagulant or antiplatelet medication.
What counts as an anticoagulant
The key categories of medication that affect bleeding risk in surgery include:
- **Vitamin K antagonists (VKAs)**: warfarin. Monitored by INR. Long half-life, unpredictable reversal without specific agents. - **Direct oral anticoagulants (DOACs)**: apixaban, dabigatran, rivaroxaban, edoxaban. Shorter half-lives, more predictable, but with limited reversal options depending on the drug. - **Antiplatelet agents**: aspirin, clopidogrel, prasugrel, ticagrelor. Used for arterial thromboprophylaxis. - **Heparins**: low-molecular-weight heparin (enoxaparin, dalteparin) and unfractionated heparin. Often used as bridging therapy around surgery.
The risk management — how far in advance to stop, whether to bridge with another agent, when to restart — differs significantly across these categories and also depends on why the anticoagulant is prescribed (atrial fibrillation, prosthetic heart valve, recent DVT, stent, etc.).
Why this matters for overseas surgery
Peri-operative anticoagulant management requires coordination between the prescribing clinician (usually your home GP, cardiologist, haematologist, or neurologist) and the surgical and anaesthetic team. For domestic procedures, this coordination happens through a shared healthcare system. For overseas procedures, the coordination has to be explicit — and often it isn't.
Two failure modes are common in overseas medical tourism:
1. **The patient stops the anticoagulant too early or too late** relative to the procedure, on their own judgement, without input from the prescribing clinician. This is a significant cause of post-operative bleeding or thrombotic complications. 2. **The overseas surgeon accepts the patient without knowing the full anticoagulation context**, proceeds based on assumptions about domestic practice, and discovers the issue intra-operatively or post-operatively.
Neither failure mode is the patient's fault — both are system failures that need to be anticipated before booking.
Before booking: the pre-operative conversation with the prescribing clinician
Before you commit to an overseas procedure, have a specific conversation with the clinician who prescribed your anticoagulant. The questions to cover:
- Is the planned procedure compatible with my current anticoagulation? - What is the recommended stop date relative to the procedure? - Do I need bridging therapy (typically enoxaparin injections) between stopping the oral agent and the procedure? - What is the recommended restart date after the procedure? - What monitoring (INR, platelet counts, etc.) is required? - Will you provide a written peri-operative plan that the overseas team can follow?
Obtain this plan in writing. Bring a copy to the overseas consultation and confirm that the overseas surgical and anaesthetic team have read it and agree with it. If they want to deviate from the plan, that deviation should be discussed with your prescribing clinician, ideally by direct email or phone.
Regional anaesthesia considerations
If your overseas procedure will involve regional anaesthesia (epidural, spinal, peripheral nerve block), the interaction with anticoagulants is particularly important. The risk of spinal or epidural haematoma — a rare but potentially catastrophic complication — is significantly increased if neuraxial anaesthesia is performed while anticoagulation is active.
Professional anaesthetic societies (including the AAGBI in the UK and ASRA in the US) publish specific time windows for when neuraxial anaesthesia can safely be performed relative to different anticoagulant regimens. These windows are different for each drug and need to be respected.
If your overseas clinic uses regional anaesthesia routinely, confirm that their anaesthetist has specific training in anticoagulation management. This is a standard area of anaesthetic practice but it is surprisingly easy to overlook in high-volume cosmetic clinics where routine protocols don't encounter anticoagulated patients often.
The bridging decision
If you are on warfarin for a high-risk indication (prosthetic heart valve, recent venous thromboembolism, atrial fibrillation with high stroke risk), your prescribing clinician may recommend bridging therapy — temporarily switching to a short-acting anticoagulant (typically enoxaparin) around the time warfarin is held for surgery. Bridging is standard for some indications and contraindicated for others; it requires specific instruction from the prescribing clinician.
The logistics of bridging around an overseas trip are non-trivial. You may be injecting yourself with enoxaparin daily for several days either side of the procedure, across travel, in an unfamiliar environment. Pre-fill the injections before travelling; make sure the overseas team knows you are on bridging; confirm where to dispose of sharps safely while travelling.
Post-operative restart
Restarting anticoagulation after an overseas procedure is often the step most likely to be mis-timed. Restarting too early increases bleeding at the surgical site; restarting too late increases thrombotic risk.
Confirm in writing before leaving the overseas clinic: when the anticoagulant should be restarted (specific date), at what dose, and whether any interim monitoring (e.g., INR if returning to warfarin) is required. For DOACs, the restart date depends on the procedure's bleeding risk; for warfarin, the overlap period with bridging therapy is important; for antiplatelets, the cardiologist may have a specific restart timeline tied to stent-related thrombosis risk.
A good overseas surgeon will send the home prescribing clinician a formal discharge note including the operative bleeding risk and recommending a restart plan. If this is not offered, ask for it explicitly.
Avoiding informal advice
The single highest-risk behaviour around anticoagulation and overseas surgery is seeking informal peri-operative advice from non-prescribing sources — forum posts, online communities, the overseas clinic's patient coordinator. The peri-operative management of anticoagulants is genuinely complex and genuinely consequential. If your prescribing clinician is not available to advise, that is a reason to postpone the procedure, not a reason to improvise.
If you are travelling without a clear written peri-operative plan from your prescribing clinician, agreed with the overseas team in advance, the safest action is to reschedule until that plan is in place.